Asada A - Search Results

1

Involvement of human liver cytochrome P4502B6 in the metabolism of propofol.

Oda Y, Hamaoka N, Hiroi T, Imaoka S, Hase I, Tanaka K, Funae Y, Ishizaki T, Asada A. Oda Y, et al. Among authors: asada a. Br J Clin Pharmacol. 2001 Mar;51(3):281-5. doi: 10.1046/j.1365-2125.2001.00344.x. Br J Clin Pharmacol. 2001. PMID: 11298076 Free PMC article.

2

Lidocaine metabolism by human cytochrome P-450s purified from hepatic microsomes: comparison of those with rat hepatic cytochrome P-450s.

Imaoka S, Enomoto K, Oda Y, Asada A, Fujimori M, Shimada T, Fujita S, Guengerich FP, Funae Y. Imaoka S, et al. Among authors: asada a. J Pharmacol Exp Ther. 1990 Dec;255(3):1385-91. J Pharmacol Exp Ther. 1990. PMID: 2262908

3

Metabolism of lidocaine by purified rat liver microsomal cytochrome P-450 isozymes.

Oda Y, Imaoka S, Nakahira Y, Asada A, Fujimori M, Fujita S, Funae Y. Oda Y, et al. Among authors: asada a. Biochem Pharmacol. 1989 Dec 15;38(24):4439-44. doi: 10.1016/0006-2952(89)90654-0. Biochem Pharmacol. 1989. PMID: 2604746

4

Metabolism of a new local anesthetic, ropivacaine, by human hepatic cytochrome P450.

Oda Y, Furuichi K, Tanaka K, Hiroi T, Imaoka S, Asada A, Fujimori M, Funae Y. Oda Y, et al. Among authors: asada a. Anesthesiology. 1995 Jan;82(1):214-20. doi: 10.1097/00000542-199501000-00026. Anesthesiology. 1995. PMID: 7832304

5

Metabolism of lidocaine by rat pulmonary cytochrome P450.

Tanaka K, Oda Y, Asada A, Fujimori M, Funae Y. Tanaka K, et al. Among authors: asada a. Biochem Pharmacol. 1994 Mar 15;47(6):1061-6. doi: 10.1016/0006-2952(94)90418-9. Biochem Pharmacol. 1994. PMID: 8147905

6

Propofol decreases the clearance of midazolam by inhibiting CYP3A4: an in vivo and in vitro study.

Hamaoka N, Oda Y, Hase I, Mizutani K, Nakamoto T, Ishizaki T, Asada A. Hamaoka N, et al. Among authors: asada a. Clin Pharmacol Ther. 1999 Aug;66(2):110-7. doi: 10.1053/cp.1999.v66.100038001. Clin Pharmacol Ther. 1999. PMID: 10460064 Clinical Trial.

7

Fentanyl inhibits metabolism of midazolam: competitive inhibition of CYP3A4 in vitro.

Oda Y, Mizutani K, Hase I, Nakamoto T, Hamaoka N, Asada A. Oda Y, et al. Among authors: asada a. Br J Anaesth. 1999 Jun;82(6):900-3. doi: 10.1093/bja/82.6.900. Br J Anaesth. 1999. PMID: 10562786 Free article.

8

Cytochrome P4502B6 and 2C9 do not metabolize midazolam: kinetic analysis and inhibition study with monoclonal antibodies.

Hamaoka N, Oda Y, Hase I, Asada A. Hamaoka N, et al. Among authors: asada a. Br J Anaesth. 2001 Apr;86(4):540-4. doi: 10.1093/bja/86.4.540. Br J Anaesth. 2001. PMID: 11573629 Free article.

9

I.v. fentanyl decreases the clearance of midazolam.

Hase I, Oda Y, Tanaka K, Mizutani K, Nakamoto T, Asada A. Hase I, et al. Among authors: asada a. Br J Anaesth. 1997 Dec;79(6):740-3. doi: 10.1093/bja/79.6.740. Br J Anaesth. 1997. PMID: 9496205 Free article. Clinical Trial.

10

Area under the plasma concentration-time curve of inorganic fluoride following sevoflurane anesthesia correlates with CYP2E1 mRNA level in mononuclear cells.

Hase I, Imaoka S, Oda Y, Hiroi T, Nakamoto T, Asada A, Funae Y. Hase I, et al. Among authors: asada a. Anesthesiology. 2000 Jun;92(6):1661-6. doi: 10.1097/00000542-200006000-00025. Anesthesiology. 2000. PMID: 10839917

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

249 results

Search Page

Filters